Epoch

Product NDC: 62839-1084
11-digit product format: 628391084
Labeler code: 62839
Product ID: 62839-1084_256b7f7a-098c-4d84-879b-8191db6c6958
Type: HUMAN OTC DRUG
Nonproprietary name: Salicylic Acid
Dosage form: GEL
Route: TOPICAL
Labeler: NSE Products, Inc.
Application: M006
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2001-06-10
Marketing end: 2028-01-01
Substance: SALICYLIC ACID
Active strength: 20 g/1000mL
NDC exclude flag: No
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62839-1084-5	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62839-1084-5	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62839-1084-5	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62839-1084-5	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62839-1084-5	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62839-1084-5	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62839-1084-5	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62839-1084-5	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62839-1084-5	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62839-1084-5	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62839-1084-5	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62839-1084-5	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	62839-1084-5	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	62839-1084-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	62839-1084-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	62839-1084-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	62839-1084-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	62839-1084-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	62839-1084-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	62839-1084-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	62839-1084-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	62839-1084-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Epoch

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
SALICYLIC ACID	20 g/1000mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
O414PZ4LPZ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
346298	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3084ac37-de1f-4218-9471-6a5ebf720eb9	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62839-1084-5	2020-01-31	C162847	48780-1	9d75b9d0-89bc-f424-e053-dadaa90a57ce	Epoch ® Acne Medication Blemish Treatment
62839-1084-5	2020-01-31	C162847	48780-1	9d75b9d0-89bc-f424-e053-dadaa90a57ce	Epoch ® Acne Medication Blemish Treatment

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Salicylic Acid	ACTIVE INGREDIENT	O414PZ4LPZ	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Salicylic Acid	ACTIVE MOIETY	O414PZ4LPZ	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Achillea Millefolium	INACTIVE INGREDIENT	2FXJ6SW4PK	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Arctium Lappa Root	INACTIVE INGREDIENT	597E9BI3Z3	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Butylene Glycol	INACTIVE INGREDIENT	3XUS85K0RA	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Coix Lacryma-Jobi Var. Ma-Yuen Seed	INACTIVE INGREDIENT	8DW238I7ZI	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
POLYETHYLENE GLYCOL 1500	INACTIVE INGREDIENT	1212Z7S33A	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Polyoxyl 40 Hydrogenated Castor Oil	INACTIVE INGREDIENT	7YC686GQ8F	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	EPOCH (SALICYLIC ACID) GEL [NSE PRODUCTS, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 54 of 54 · 1,079 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Acne Control	CREAM	Walgreen	fc60cccb-405b-e49e-e053-6394a90a5a12	2023-09-11	Warnings	Exact identifier application number: M006
AnubisMed	AZELAIC ACID, SALICYLIC ACID	ANUBIS COSMETICS SL	ebf3153d-30f5-54e4-e053-2995a90a74b1	2023-09-05	Warnings	Exact identifier application number: M006
AnubisMed	GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID	ANUBIS COSMETICS SL	eca95dde-cb57-2ab6-e053-2995a90af84f	2023-09-05	Warnings	Exact identifier application number: M006
Anubis Barcelona	PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN	ANUBIS COSMETICS SL	eb9244ea-6102-3cbe-e053-2a95a90ab8f6	2023-09-01	Warnings	Exact identifier application number: M006
Anubis Barcelona Regul Oil	PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL	ANUBIS COSMETICS SL	eb8e5beb-4452-58c2-e053-2a95a90a66e0	2023-09-01	Warnings	Exact identifier application number: M006
Anubis Barcelona Regul Oil	CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE	ANUBIS COSMETICS SL	eb68c3ab-7835-1a1c-e053-2995a90a0d66	2023-09-01	Warnings	Exact identifier application number: M006
Anubis Barcelona Regul OIl	PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT	ANUBIS COSMETICS SL	eb905bd0-c600-b8b2-e053-2995a90ad259	2023-09-01	Warnings	Exact identifier application number: M006
Anubis Barcelona Regul Oil	PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT	ANUBIS COSMETICS SL	eb7c418b-8bee-26a3-e053-2a95a90a4e96	2023-09-01	Warnings	Exact identifier application number: M006
ACNE CLEANSING	SALICYLIC ACID	CLINIQUE LABORATORIES LLC	7bae5802-cf51-4b41-9d7c-d72f1eb4c4af	2023-08-30	Warnings	Exact identifier application number: M006
Gly-Sal 2-2 Pads	SALICYLIC ACID	Topiderm, Inc.	a92a9ffb-5c5b-43a4-b669-04667324920b	2023-02-16	Warnings	Exact identifier application number: M006
Derma E Acne Clarifying Mask	SULFUR	derma e	55df8fb4-abc3-43fe-b89b-6e7d638b27a6	2023-02-14	Warnings	Exact identifier application number: M006
Replenix Acne Gly-Sal 2-2 Foaming Cleanser	SALICYLIC ACID	Topiderm, Inc.	811dbf95-2b39-45c5-99a2-33c3c9d19570	2019-12-19	Warnings	Exact identifier application number: M006
REPLENIX ACNE SOLUTIONS WASH	BENZOYL PEROXIDE	Topiderm, Inc.	8dc2d27d-3cc4-4874-b4c2-32607849b205	2019-12-17	Warnings	Exact identifier application number: M006
REPLENIX ACNE Solution BENZOYL PEROXIDE WASH	BENZOYL PEROXIDE	Topiderm, Inc.	235e9dd5-13f2-4078-9807-1d87fd9e6cba	2019-12-17	Warnings	Exact identifier application number: M006
Replenix Acne	BENZOYL PEROXIDE	Topiderm, Inc	03d4c298-8f44-41f7-b086-96ae836152bb	2019-10-31	Warnings	Exact identifier application number: M006
Replenix Acne	BENZOYL PEROXIDE	Topiderm, Inc.	c12f9005-a549-4447-9beb-df7126f77df1	2019-10-31	Warnings	Exact identifier application number: M006
Gly-Sal 10-2 Pads	SALICYLIC ACID	Topiderm, Inc.	b39e845d-4c40-4f9e-9cb5-a8386f326652	2019-10-23	Warnings	Exact identifier application number: M006
Gly-Sal 5-2 Pads	SALICYLIC ACID	Topiderm, Inc.	e73bd26c-cdc2-47ab-94e8-3bc49a9b19e8	2019-10-22	Warnings	Exact identifier application number: M006
SKIN MEDICA Purifying Foaming Wash	SALICYLIC ACID	Allergan, Inc.	064d9e2b-077f-4229-b653-666fc5479ae2	2013-03-01	Warnings	Exact identifier application number: M006

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62839-1084-5	62839108405	1 TUBE in 1 POUCH (62839-1084-5) / 15 mL in 1 TUBE	1 tube	2001-06-10	2028-01-01	No	No	Historical